Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease

Journal of Indian Society of Periodontology

Volumn 17, Issue 3, 2013, Pages 292-301

  Grover, Harpreet ^a   Luthra, Shailly ^a  

^a SGT UNIVERSITY   (India)

Author keywords

Diabetes mellitus; hyperglycemia; hyperlipidemia; immune response; insulin resistance; periodontal disease

Indexed keywords

EID: 84882422403     PISSN: 0972124X     EISSN: 09751580     Source Type: Journal    
DOI: 10.4103/0972-124X.115642     Document Type: Review

References (151)

1. Mealey BL. Diabetes mellitus. In: Rose LF, Genco RJ, Mealey BL, Cohen DW. Periodontal medicine, 1st ed. Toronto: BC Decker Publishers; 2000. p. 121 50.
2. Rose LF, Mealey BL, Genco RJ, Cohen DW. Periodontics: Medicine, Surgery, and Implants, 1st ed. USA: Elsevier Mosby; 2004. p. 789 880.
3. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ 1998; 159 Suppl 8:S1 29.
4. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, et al. The 1997 American diabetes association and 1999 world health organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000;23:1108 12.
5. Loe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 1993;16:329 34.
6. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: Current concepts. J Periodontol 1992;63:322 31.
7. Liljenberg B, Lindhe J, Berglundh T, Dahlén G, Jonsson R. Some microbiological, histopathological and immuno histochemical characteristics of progressive periodontal disease. J Clin Periodontol 1994;21:720 7.
8. Page RC, Offenbacher S, Schroeder HE, Seymour JG, Kornman KS. Advances in the pathogenesis of periodontitis: Summary of developments, clinical implications and future directions. Periodontol 2000 1997;14:216 48.
9. Papapanou PN. Epidemiology of periodontal diseases: An update. J Int Acad Periodontol 1999;1:110 6.
10. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol 1996;1:821 78.
11. Syrajanen J, Peltola J, Valtonen V, Iivanainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middle aged men. J Intern Med 1989;225:179 84.
12. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. Br Med J 1993;306:688 91.
13. Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesäniemi YA, Syrjälä SL, et al. Association between dental health and acute myocardial infarction. Br Med J 1989;298:779 81.
14. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, et al. Periodontal infection as a risk factor for preterm low birth weight. J Periodontol 1996; 67(Suppl.):1103 13.
15. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two way relationship. Ann Periodontal 1998;3:51 61.
16. Zambon JJ, Reynolds H, Fisher JG, Shlossman M, Dunford R, Genco RJ. Microbiological and immunological studies of adult periodontitis in patients with non insulin dependent diabetes mellitus. J Periodontol 1988;59:23 31.
17. Manoucher PM, Spagnuolo PJ, Rodman HM, Bissada NF. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol 1981;52:410 5.
18. McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ. Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol 1981;52:167 73.
19. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000 2007;44:127 53.
20. Mealey B. Diabetes and periodontal diseases. J Periodontol 1999;70:935 9.
21. Cianciola LJ, Park BH, Bruck E, Mosovich L, Genco RJ. Prevalence of periodontal disease in insulin dependent diabetes mellitus (juvenile diabetes). J Am Dent Assoc 1982;104:653 60.
22. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non insulin dependent diabetes mellitus. J Periodontol 1991;62:123 31.
23. Safkan Seppala B, Ainamo J. Periodontal conditions in insulin dependent diabetes mellitus. J Clin Periodontal 1992;19:24 9.
24. Listgarten MA, Ricker FH Jr, Laster L, Shapiro J, Cohen DW. Vascular basement lamina thickness in the normal and inflamed gingiva of diabetics and non diabetics. J Periodontol 1974;45;676 84.
25. Manouchehr Pour M, Spagnuolo PJ, Rodman HM, Bissada NF. Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res 1981;60:729 30.
26. Sorsa T, Ingman T, Suomalainen K, Halinen S, Saari H, Konttinen YT, et al. Cellular source and tetracycline inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol 1992;19:146 9.
27. Zambon JJ, Reynolds H, Fisher JG, Shlossman M, Dunford R, Genco RJ. Microbiological and immunological studies of adult periodontitis in patients with noninsulin dependent diabetes mellitus. J Periodontal 1988;59:23 31.
28. Pociot F, Briant L, Jongeneel CV, Mölvig J, Worsaae H, Abbal M, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF alpha and TNF beta by human mononuclear cells: A possible link to insulin dependent diabetes mellitus. Eur J Immunol 1993;23:224 31.
29. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF ? secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997;24:8 16.
30. Doxey DL, Nares S, Park B, Trieu C, Cutler CW, lacopino AM. Diabetes induced impairment of macrophage cytokine release in a rat model: Potential role of serum lipids. Life Sci 1998;63:1127 36.
31. Doxey DL, Cutler CW, lacopino AM. Diabetes prevents periodontitis induced increases in gingival platelet derived growth factor B and interleukin 1 beta in a rat model. J Periodontal 1998;69:113 9.
32. Iacopino AM. Diabetic periodontitis: Possible lipid induced defect in tissue repair through alteration of macrophage phenotype and function. Oral Dis 1995;1:214 29.
33. Doxey DL, Ng MC, Dill RE, lacopino AM. Platelet derived growth factor levels in wounds of diabetic rats, Life Sci 1995;57:1111 23.
34. Cutler CW, Machen RL, Jotwani R, lacopino AM. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J Periodontol 1999;70:1313 21.
35. Cutler CW, Shinedling EA, Nunn M, Jotwani R, Kim BO, Nares S, et al. Association between periodontitis and hyperlipidemia: Cause or effect? J Periodontol 1999;70:1429 34.
36. Prabhu A, Michalowicz BS, Mathur A. Detection of local and systemic cytokines in adult periodontitis. J Periodontol 1996;67:515 22.
37. Salvi GE, Brown CE, Fujihashi K, Kiyono H, Smith FW, Beck JD, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodont Res 1998;33:212 25.
38. Ebersole JL, Cappelli D, Mott G, Kesavalu L, Holt SC, Singer RE. Systemic manifestations of periodontitis in the non human primate. J Periodont Res 1999;34:358 62.
39. Ebersole JL, Cappelli D. Acute phase reactants in infections and inflammatory diseases. Periodontol 2000 2000;23:19 49.
40. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998;9:248 66.
41. Seymour GJ, Gemmell E. Cytokines in periodontal disease: Where to from here? Acta Odontol Scand 2001;59:167 73.
42. Preshaw P, Foster N, Taylor J. Cross susceptibility between periodontal disease and type 2 diabetes mellitus: An immunobiological perspective. Periodontol 2000 2007;45:138 57.
43. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: Molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005;288:H2031 41.
44. Iacopino AM, Cutler CW. Pathophysiological relationships between periodontitis and systemic disease: Recent concepts involving serum lipids. J Periodontol 2000;71:1375 84.
45. Iacopino AM. Periodontitis and Diabetes interrelationships: Role of Inflammation. Ann Periodontol 2001;6:125 37.
46. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613 28.
47. Kim DK, Escalante DA, Garber AJ. Prevention of atherosclerosis in diabetes: Emphasis on treatment for the abnormal lipoprotein metabolism of diabetes, Clin Ther 1993;l5:766 78.
48. Tilvis RS, Miettinen TA. Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin dependent diabetic women. J Clin Endocrinol Metab 1985;61:741 5.
49. Horrobin DF. The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 1988;31:181 97.
50. Hagve TA. Effects of unsaturated fatty acids on cell membrane functions. Scand J Clin Lab Inuest 1988;48:381 8.
51. Stubbs CD, Smith AD. The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 1984;779:89 137.
52. Clandinin MT, Cheema S, Field CJ, Garg ML, Venkatraman J, Clandinin TR. Dietary fat: Exogenous determination of membrane structure and cell function. FASEB J 1991;5:2761 9.
53. Arisaka M, Arisaka O, Yamashiro Y. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II, The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. Prostaglandins Leukot Essent Fatty Acids 1991;43:197 201.
54. Dutta Roy AK. Insulin mediated processes in platelets, erythrocytes, and monocytes/macrophages: Effects of essential fatty acid metabolism. Prostaglandins Leukot Essent Fatty Acids 1994,51:385 99.
55. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF ?secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997 24:8 16.
56. Salvi GE, Beck JD, Offenbacher S. PGE2, IL 1?, and TNF ? responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998;3:40 50.
57. Thomas CE, Jackson RL, Ohlweiler DF, Ku G. Multiple lipid oxidation products in low density lipoproteins induce interleukin 1 beta release from human blood mononuclear cells. J Lipid Res 1994;35:417 27.
58. Jovinge S, Ares MP, Kallin B, Nilsson J. Human monocytes/macrophages release TNF ? in response to ox LDL. Arterioscler Thromb Vasc Biol 1996;16:1573 9.
59. Pociot F, Mlvig J, Wogensen L, Worsaae H, Dalbge H, Baek L, et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin dependent diabetes mellitus. Scand J Immunol 1991;33:37 49.
60. Alley CS, Reinhardt RA, Maze CA, DuBois LM, Wahl TO, Duckworth WC, et al. HLA D and T lymphocyte reactivity to specific periodontal pathogens in type 1 diabetic periodontitis. J Periodontol 1993;64:974 9.
61. Sakallioglu EE, Ayas B, Lutfioglu M, Keles GC, Acikgoz G, Firatli E. Gingival levels of monocyte chemoattractant protein 1 (MCP 1) in diabetes mellitus and periodontitis: An experimental study in rats. Clin Oral Invest 2008;12:83 9.
62. Emingil G, Atilla G, Huseyinov A. Gingival crevicular fluid monocyte chemoattractant protein 1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 2004;31:829 34.
63. Garlet GP, Martins W Jr, Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expressionin different forms of human periodontal disease. J Periodontal Res 2003;38:210 7.
64. Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S. Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 2000;121:437 43.
65. Tashimo A, Mitamura Y, Nagai S, Nakamura Y, Ohtsuka K, Mizue Y, et al. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein 1 in patients with diabetic retinopathy. Diabet Med 2004;21:1292 7.
66. Gurav A, Jadhav V. Periodontitis and risk of diabetes. J Diabetes 2011;3:21 8.
67. Festa A, D'Agostino RD, Howard G, Mykkanen I, Tracy RP, Haffner SM. Chronic subclinical inflammation as a part of the insulin resistance syndrome. The insulin resistance atherosclerosis study (IRAS). Circulation 2000;102:42 7.
68. Casazza JP, Veech RL. The measurement of xylulose 5 phosphate, ribulose 5 phosphate, and combined sedoheptulose 7 phosphate and ribose 5 phosphate in liver tissue. Anal Biochem 1986;159:243 8.
69. Curi TC, De Melo MP, Palanch AC, Miyasaka CK, Curi R. Percentage of phagocytosis, production of O2, H2O2, and NO, and antioxidant enzyme activities of rat neutrophils in culture. Cell Biochem Funct 1998;16:43 9.
70. Bellavite P. The superoxide forming enzymatic system of phagocytes. Free Radic Biol Med 1988;4:225 61.
71. Cerillo A. Cardiovascular effects of acute hyperglycemia: Pathophysiological underpinnings. Diab Vasc Dis Res 2008;5:260 8.
72. Spinetti G, Kraenkel N, Emanuuel C, Madeddu P. Diabetes and vessel wall remodelling: From mechanistic insights to regenerative therapies. Cardiovasc Res 2008;78:265 73.
73. Costa Rosa LF, Safi DA, Cury Y, Curi R. The effect of insulin on macrophage metabolism and function. Cell Biochem Funct 1996;14:33 42.
74. Otton R, Mendonca JR, Curi R. Diabetes causes marked changes in lymphocyte metabolism. J Endocrinol 2002;174:55 61.
75. Gray GR, Stamatoyannopoulos G, Naiman SC, Kliman MR, Klebanoff SJ, Austin T, et al. Neutrophil dysfunction, chronic granulomatous disease, and non spherocytic haemolytic anaemia caused by complete deficiency of glucose 6 phosphate dehydrogenase. Lancet 1973;2:530 4.
76. Roos D, van Zwieten R, Wijnen JT, Gómez Gallego F, de Boer M, Stevens D, et al. Molecular basis and enzymatic properties of glucose 6 phosphate dehydrogenase volendam, leading to chronic non spherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 1999;94:2955 62.
77. Newsholme P, Lima MM, Procopio J, Pithon Curi TC, Doi SQ, Bazotte RB, et al. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res 2003;36:153 63.
78. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon Curi TC, et al. Molecular mechanisms of glutamine action. J Cell Physiol 2005;204:392 401.
79. Ogle CK, Ogle JD, Mao JX, Simon J, Noel JG, Li BG, et al. Effect of glutamine on phagocytosis and bacterial killing by normal and pediatric burn patient neutrophils. JPEN J Parenter Enteral Nutr 1994;18:128 33.
80. Pithon Curi TC, Schumacher RI, Freitas JJ, Lagranha C, Newsholme P, Palanch AC, et al. Glutamine delays spontaneous apoptosis in neutrophils. Am J Physiol Cell Physiol 2003;284:C1355 61.
81. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003;66:1499 503.
82. Aljada A, Friedman J, Ghanim H, Mohanty P, Hofmeyer D, Chaudhuri A, et al. Glucose ingestion induces an increase in intranuclear nuclear factor kappa B, a fall in cellular inhibitor kappa B, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism 2006;55:1177 85.
83. Chapple IL, Matthews JB. The role of reactive oxygen species (ROS) and antioxidant species in periodontal tissue destruction. Periodontol 2000 2007;43:160 232.
84. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Joshua T. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44 84.
85. Valko M, Morris H, Cronin MT. Metals toxicity and oxidative stress. Curr Med Chem 2005;12:1161 208.
86. Sugano N, Kawamoto K, Numazaki H, Murai S, Ito K. Detection of mitochondrial DNA mutations in human gingival tissues. J Oral Sci 2000;42:221 3.
87. Takane M, Sugano N, Iwasaki H, Iwano Y, Shimizu N, Ito K. New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J Periodontol 2002;73:551 4.
88. Sculley DV, Langley Evans SC. Periodontal disease is associated with lower antioxidant capacity in whole saliva and evidence of increased protein oxidation. Clin Sci 2003;105:167 72.
89. Panjamurthy K, Manoharan S, Ramachandran CR. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett 2005;10:255 64.
90. Salvi GE, Yalda B, Collins JG, Jones BH, Smith FW, Arnold RR, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin dependent diabetes mellituspatients. J Periodontol 1997;68:127 35.
91. Ramamurthy NS, Zebrowski EJ, Golub LM. Insulin reversal of alloxan diabetes induced changes in gingival collagen metabolism of the rat. J Periodontal Res 1974;9:199 206.
92. Brownlee M. Glycation and diabetic complications. Diabetes 1994;43:836 41.
93. Monnier VM, Glomb M, Elgawish A, Sell DR. The mechanism of collagen cross linking in diabetes. A puzzle nearing resolution. Diabetes 1996;45:67 72.
94. Golub LM, Lee HM, Ryan ME. Tetracyclines inhibit connective tissue breakdown by multiple non antimicrobial mechanisms. Adv Dent Res 1998;12:12 26.
95. Ryan M, Ramamurthy NS, Sorsa T, Golub LM. MMP mediated events in diabetes. Ann N Y Acad Sci 1999;878:311 34.
96. Sorsa T, Ingman T, Suomalainen K, Halinen S, Saari H, Konttinen YT, et al. Cellular source and tetracycline inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol 1992;19:146 9.
97. Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, et al. Cross linking of the extracellular matrix by the Maillard reaction in aging and diabetes: An update on ''a puzzle nearing resolution''. Ann N Y Acad Sci 2005;1043:533 44.
98. Wang X, Shen X, Li X, Agrawal CM. Age related changes in the collagen network and toughness of bone. Bone 2002;31:1 7.
99. Vashisht D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone 2001;28:195 201.
100. Verzijl N, DeGroot J, Ben ZC, Brau Benjamin O, Maroudas A, Bank RA, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: A possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002;46:114 23.
101. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical Type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001;14:525 8.
102. McCarthy AD, Etcheverry SB, Bruzzone L, Lettierri G, Barrio DA, Cortizo AM. Non enzymatic glycosylation of a type I collagen matrix: Effects on osteoblastic development and oxidative stress. BMC Cell Biol 2001;2:16 21.
103. Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC. A role for advanced glycation end products in diminished bone healing in Type 1 diabetes. Diabetes 2003;52:1502 10.
104. Takagi M, Kasayama S, Yamamoto T, Motomura T, Hashimoto K, Yamamoto H, et al. Advanced glycation end products stimulate interleukin 6 production by human bone derived cells. J Bone Miner Res 1997;12:439 46.
105. Valerio G, Franzese A, Esposito Del Puente A, Formicola S, Di Maio S, Contaldo F, et al. Increased urinary excretion of collagen cross links in Type 1 diabetic children in the first 5 years of disease. Horm Res 1999;51:173 7.
106. Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, et al. Metabolic improvement of poorly controlled noninsulin dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 1997;82:2915 20.
107. Okazaki R, Miura M, Toriumi M, Taguchi M, Hirota Y, Fukumoto S, et al. Short term treatment with troglitazone decreases bone turnover in patients with Type 2 diabetes mellitus. Endocr J 1999;46:795 801.
108. Erbagci AB, Araz M, Ergabci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in Type 2 diabetes mellitus. Clin Biochem 2002;35:263 8.
109. Cloos C, Wahl P, Hasslacher C, Traber L, Kistner M, Jurkuhn K, et al. Urinary glycosylated, free and total pyridinolines and free and total deoxypyridinoline in diabetes mellitus. Clin Endocrinol 1998;48:317 23.
110. Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stren D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Atheroscler Thromb 1994;14:1521 8.
111. Vlassara H, Bucala R. Recent progress in advanced glycation and diabetic vascular disease: Role of advanced glycation end product receptors. Diabetes 1996;45 Suppl 3:S65 6.
112. Lalla E, Lamster IB, Drury S, Fu C, Schmidt AM. Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: Potential mechanisms underlying diabetic complications, including diabetes associated periodontitis. Periodontol 2000 2000;23:50 62.
113. Lowe GD. Etiopathogenesis of cardiovascular diseases, hemostasis, thrombosis and vascular medicine. Ann Periodontol 1998;3:121 6.
114. Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, et al. RAGE: A novel cellular receptor for advanced glycation end products. Diabetes 1996;45 Suppl 3:S77 80.
115. Paques M, Massin P, Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab 1997;23:125 30.
116. Chiarelli F, Santilli F, Mohn A. Role of growth factors in the development of diabetic complications. Horm Res 2000;53:53 67.
117. Unlu F, Gurdal Guneri P, Hekimgil M, Yesilbek B, Boyacioglu H. Expression of vascular endothelial growth factor in human periodontal tissues: Comparison of healthy and diabetic patients. J Periodontol 2003;74:181 7.
118. Graves DT, Liu R, Oates TW. Diabetes enhanced inflammation and apoptosis: Impact on periodontal pathosis. Periodontol 2000 2007;45:128 37.
119. Ohnishi T, Bandow K, Kakimoto K, Machigashira M, Matsuyama T, Matsuguchi T. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes. J Periodontal Res 2009;44:43 51.
120. Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y. A proposed model linking inflammation to obesity, diabetes and periodontal infections. J Periodontol 2005;76:2075 84.
121. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL. insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 2000;85:3770 8.
122. Vassiliadis S, Dragiotis V, Protopapadakis E, Athanassakis I, Mitlianga P, Konidaris K, et al. The destructive action of IL 1alpha and IL b in IDDM is a multistage process: Evidence and confirmation by apoptotic studies, induction of intermediates and electron microscopy. Mediators Inflamm 1999;8:85 91.
123. Sjoholm A. Aspects of the involvement of interleukin 1 and nitric oxide in the pathogenesis of insulin dependent diabetes mellitus. Cell Death Diff 1998;5:461 8.
124. Moller DE. Potential role of TNF alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 2000;11:212 7.
125. Qi C, Pekala PH. Tumor necrosis factor alpha induced insulin resistance in adipocytes. Proc Soc Exp Biol Med 2000;223:128 35.
126. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor ?: Direct role in obesity linked insulin resistance. Science 1993;259:87 91.
127. Netea MG, Hancu N, Blok WL, Grigorescu Sido P, Popa L, Popa V, et al. Interleukin 1 beta, tumour necrosis factor alpha and interleukin 1 receptor antagonist in newly diagnosed insulin dependent diabetes mellitus: Comparison to long standing diabetes and healthy individuals. Cytokine 1997;9:284 7.
128. Van Assche G, Rutgeerts P. Anti TNF agents in Crohn's disease. Exp Opin Invest Drugs 2000;9:103 11.
129. Bresnihan B, Cunnane G. Interleukin 1 receptor antagonist. Rheum Dis Clin North Am 1998;24:615 28.
130. Knopp RH, Brown WV, Dujovne CA, Farquhar JW, Feldman EB, Goldberg AC, et al. Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia. Am J Med 1987;83:50 9.
131. Farnier M, Davignon J. Current and future treatment of hyperlipidemia: The role of statins. Am J Cardiol 1998;82:3 10J.
132. Ordovas JM. The genetics of serum lipid responsiveness to dietary interventions. Proc Nutr Soc 1999;58:171 87.
133. Knopp RH. Introduction: Low saturated fat, high carbohydrate diets: Effects on triglyceride and LDL synthesis, the LDL receptor, and cardiovascular disease risk. Proc Soc Exp Biol Med 2000;225:175 7.
134. Roche HM, Gibney MJ. Effect of long chain n 3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am J Clin Nutr 2000;71 (1 Suppl):232S 7S.
135. Fernandez ML. Soluble fiber and nondigestible carbohydrate effects on plasma lipids and cardiovascular risk. Curr Opin Lipidol 2001;12:35 40.
136. Arisaka M, Arisaka O, Yamashiro Y. Fatty acid and prostaglandin metabolism in children with diabetes mellitus II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. Prostaglandins Leuko Essent Fatty Acids 1991;43:197 201.
137. Houtsmuller AJ, van Hal Ferwerda J, Zahn KJ, Henkes HE. Favorable influences of linoleic acid on the progression of diabetic micro and macroangiopathy in adult onset diabetes mellitus. Prog Lipid Res 1981;20:377 86.
138. Jamal GA, Carmichael H. The effect of gamma linolenic acid on human diabetic peripheral neuropathy: A double blind placebo controlled trial. Diabet Med 1990;7:319 23.
139. Takahashi R, Inoue J, Ito H, Hibino H. Evening primrose oil and Fish oil in non insulin dependent diabetes. Prostaglandins Leuko Essent Fatty Acids 1993;49:569 71.
140. Tariq T, Close C, Dodds R, Viberti GC, Lee T, Vergani D. The effect of fish oil on the remission of type 1 (insulin dependent) diabetes in newly diagnosed patients. Diabetologia 1989;32:765.
141. Requirand P, Gibert P, Tramini P, Cristol JP, Descomps B. Serum fatty acid imbalance in bone loss: Example with periodontal disease, Clin Nutr 2000;19:271 6.
142. Grimble RF. Dietary manipulation of the inflammatory response. Proc Nutr Soc 1992;51:285 94.
143. Grimble RF. Nutritional modulation of cytokine biology. Nutrition 1998;14:634 40.
144. Chu X, Newman J, Park B, Nares S, Ordonez G, lacopino AM. In vitro alteration of macrophage phenotype and function by serum lipids. Cell Tiss Res 1999;296:331 7.
145. Nicholson AS, Sklar M, Barnard ND, Gore S, Sullivan R, Browning S. Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a Low fat vegetarian diet. Prev Med 1999;29:87 91.
146. Heilbronn LK, Noakes M, Clifton PM. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 1999;22: 889 95.
147. Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, et al. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study. Diabetes Care 1997;20:913 21.
148. Grossi SG, Skrepcinski FB, Decaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol 1996;67:1094 102.
149. Miller LS, Manwell MA, Newbold D, Reding ME, Rasheed A, Blodgett J, et al. The relationship between reduction in periodontal inflammation and diabetes control: A report of 9 cases. J Periodontol 1992;63:843 8.
150. Kiran M, Arpak N, Unsal E, Erdogan MF. The effect of improved periodontal health on metabolic control in Type II diabetes mellitus. J Clin Periodontol 2005;32:266 72.
151. Singh S, Kumar V, Kumar S, Subbappa A. The effect of periodontal therapy on glycemic control in patients with Type 2 diabetes mellitus: A randomized controlled clinical trial. Int J Diabetes Dev Ctries 2008;28:38 44.